Ashland (NYSE:ASH – Get Free Report) is set to issue its quarterly earnings data after the market closes on Tuesday, April 30th. Analysts expect the company to announce earnings of $1.19 per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.
Ashland (NYSE:ASH – Get Free Report) last issued its earnings results on Wednesday, January 31st. The basic materials company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.24. Ashland had a net margin of 7.62% and a return on equity of 5.95%. The company had revenue of $473.00 million during the quarter, compared to analysts’ expectations of $478.69 million. During the same period last year, the company posted $0.97 earnings per share. The firm’s quarterly revenue was down 9.9% compared to the same quarter last year. On average, analysts expect Ashland to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Ashland Trading Down 0.4 %
Shares of Ashland stock opened at $95.63 on Tuesday. Ashland has a 12-month low of $70.82 and a 12-month high of $103.43. The company has a current ratio of 3.30, a quick ratio of 1.88 and a debt-to-equity ratio of 0.44. The stock has a market cap of $4.79 billion, a PE ratio of 31.35 and a beta of 0.92. The company has a 50-day moving average of $95.00 and a two-hundred day moving average of $85.83.
Analyst Ratings Changes
Read Our Latest Research Report on Ashland
Ashland Company Profile
Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.
Read More
- Five stocks we like better than Ashland
- What is a Special Dividend?
- Zscaler’s Potential Upside Continues to Explode
- ESG Stocks, What Investors Should Know
- 3 A.I. Stocks to Watch Out For Not Named NVIDIA
- Investing In Preferred Stock vs. Common Stock
- 2 Stocks to Benefit From New Sanctions on Russian Aluminum
Receive News & Ratings for Ashland Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashland and related companies with MarketBeat.com's FREE daily email newsletter.